MetLife Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

MetLife Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-49,282	Closed	-$2.59M	–	2354
2020 Q3	$2.59M	Sell	49,282 -2,576	-5%	-$107K	0.03%	613
2020 Q2	$1.73M	Buy	51,858 +3,744	+8%	+$119K	0.02%	786
2020 Q1	$1.31M	Buy	48,114 +4,318	+10%	+$120K	0.02%	791
2019 Q4	$864K	Hold	43,796	–	–	0.01%	1166
2019 Q3	$568K	Hold	43,796	–	–	0.01%	1352
2019 Q2	$545K	Hold	43,796	–	–	0.01%	1429
2019 Q1	$636K	Buy	43,796 +8,123	+23%	+$104K	0.01%	1310
2018 Q4	$394K	Hold	35,673	–	–	﹤0.01%	1520
2018 Q3	$938K	Hold	35,673	–	–	0.01%	1159
2018 Q2	$730K	Buy	35,673 +3,455	+11%	+$74.1K	0.01%	1180
2018 Q1	$585K	Hold	32,218	–	–	0.01%	1282
2017 Q4	$449K	Buy	+32,218	New	+$436K	0.01%	1461

MetLife Investment Management's MNTA Position: Q4 2020 in Review

MetLife Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 49,282 shares — an estimated $2.59M sold.

MetLife Investment Management first reported a position in MNTA in Q4 2017 and held it in 12 quarters. The position peaked at $2.59M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

MetLife Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
MetLife Investment Management sold 49,282 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $2.59M.
MetLife Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2017 and held it in 12 quarters.
MetLife Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $2.59M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on MetLife Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.